CoChat

Potential Repurposing of Known Drugs as Potent Bacterial β-Glucuronidase Inhibitors

Open access
Ahmad, Syed, Hughes, Mark A., Yeh, Li-An, Scott, John E. · 2012 · SLAS Discovery

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.

Abstract

The active metabolite of the chemotherapeutic irinotecan, SN-38, is detoxified through glucuronidation and then excreted into the gastrointestinal tract. Intestinal bacteria convert the glucuronidated metabolite back to the toxic SN-38 using β-glucuronidase (GUS), resulting in debilitating diarrhea. Inhibiting GUS activity may relieve this side effect of irinotecan. In this study, we sought to determine whether any known drugs have GUS inhibitory activity. We screened a library of Food and Drug Administration-approved drugs with a cell-free biochemical enzyme assay using purified bacterial GUS. After triage, five drugs were confirmed to inhibit purified bacterial GUS. Three of these were the monoamine oxidase inhibitors nialamide, isocarboxazid, and phenelzine with average IC(50) values for inhibiting GUS of 71, 128, and 2300 nM, respectively. The tricyclic antidepressant amoxapine (IC(50) = 388 nM) and the antimalarial mefloquine (IC(50) = 1.2 µM) also had activity. Nialamide, isocarboxazid, and amoxapine had no significant activity against purified mammalian GUS but showed potent activity for inhibiting endogenous GUS activity in a cell-based assay using living intact Escherichia coli with average IC(50) values of 17, 336, and 119 nM, respectively. Thus, nialamide, isocarboxazid, and amoxapine have potential to be repurposed as therapeutics to reduce diarrhea associated with irinotecan chemotherapy and warrant further investigation for this use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1087057112444927

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 50

Metadata

Authors
Ahmad, S., Hughes, M. A., Yeh, L.-A., & Scott, J. E.
Affiliations
North Carolina Central University (US)
Corresponding author
Scott, John E.
Venue
SLAS Discovery
Publisher
Elsevier BV
Published
2012-08
Volume
17
Issue
7
Pages
957-965
ISSN
2472-5552 (ISSN-L)
OpenAlex
W2162578613
Cited by
44
References
31
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 1 · 2021: 7 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 2 · 2015: 3 · 2014: 1 · 2013: 1
FWCI
1.81
Type
journal article
Language
en
Open access
Licence
Locations
  • SLAS DISCOVERY (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1sc2gm081129-01)
  • National Institute of General Medical Sciences (1SC2GM081129, SC2 GM081129)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Keywords
drug repurposing, β-glucuronidase inhibition, irinotecan, SN-38, glucuronidation, nialamide, isocarboxazid, phenelzine, amoxapine, mefloquine, monoamine oxidase inhibitors, tricyclic antidepressants, Escherichia coli, drug screening
MeSH terms
Irinotecan, Amoxapine, Antineoplastic Agents, Phytogenic, Camptothecin, Drug Evaluation, Preclinical, Enzyme Inhibitors, Escherichia coli, Glucuronidase, Isocarboxazid, Monoamine Oxidase Inhibitors, Nialamide, Phenelzine, Mefloquine, Escherichia coli Proteins, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Potential Repurposing of Known Drugs as Potent Bacterial β-Glucuronidase Inhibitors. https://app.cochat.ai/papers/10.1177/1087057112444927
The paper
Ahmad, S., Hughes, M. A., Yeh, L.-A., & Scott, J. E. (2012). Potential Repurposing of Known Drugs as Potent Bacterial β-Glucuronidase Inhibitors. SLAS Discovery. https://doi.org/10.1177/1087057112444927

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.